RALBP1 and Leber congenital amaurosis: Gene therapy resulted in incomplete recovery of the levels of RALBP-1 in the RPE of rd12 mice, indicating that this may also occur in LCA patients undergoing gene therapy and be one of the main causes of observed delayed dark adaption.